Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which met the analyst consensus estimate. This is a 271.43 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $106.506 million which beat the analyst consensus estimate of $92.088 million by 15.66 percent. This is a 158.87 percent increase over sales of $41.143 million the same period last year.